Kits Eyecare (TSE:KITS)
TSX:KITS
Canadian Market

Kits Eyecare (KITS) Stock Price & Analysis

18 Followers

KITS Stock Chart & Stats

Day’s RangeC$0 - C$0
52-Week RangeC$2.04 - C$5.60
Previous CloseC$4.69
Volume2.37K
Average Volume (3M)23.72K
Market Cap
C$146.61M
Enterprise ValueC$147.26M
Total Cash (Recent Filing)C$18.79M
Total Debt (Recent Filing)C$19.44M
Price to Earnings (P/E)-44.4
Beta0.46
Aug 10, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding31,316,452
10 Day Avg. Volume12,402
30 Day Avg. Volume23,718
Standard Deviation0.16
R-Squared0.00088
Alpha0.00053
Financial Highlights & Ratios
Price to Book (P/B)11.59
Price to Sales (P/S)5.72
Price to Cash Flow (P/CF)1.40
P/FCF Ratio1.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0


Financials

Annual

KITS FAQ

What was Kits Eyecare’s price range in the past 12 months?
Kits Eyecare lowest stock price was C$2.04 and its highest was C$5.60 in the past 12 months.
    What is Kits Eyecare’s market cap?
    Currently, no data Available
    When is Kits Eyecare’s upcoming earnings report date?
    Kits Eyecare’s upcoming earnings report date is Aug 10, 2023 which is in 72 days.
      How were Kits Eyecare’s earnings last quarter?
      Kits Eyecare released its earnings results on May 10, 2023. The company reported -C$0.03 earnings per share for the quarter, beating the consensus estimate of -C$0.04 by C$0.01.
        Is Kits Eyecare overvalued?
        According to Wall Street analysts Kits Eyecare’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Kits Eyecare pay dividends?
          Kits Eyecare does not currently pay dividends.
          What is Kits Eyecare’s EPS estimate?
          Kits Eyecare’s EPS estimate is -C$0.04.
            How many shares outstanding does Kits Eyecare have?
            Kits Eyecare has 31,260,237 shares outstanding.
              What happened to Kits Eyecare’s price movement after its last earnings report?
              Kits Eyecare reported an EPS of -C$0.03 in its last earnings report, beating expectations of -C$0.04. Following the earnings report the stock price went up 6.576%.
                Which hedge fund is a major shareholder of Kits Eyecare?
                Currently, no hedge funds are holding shares in TSE:KITS

                ---

                Kits Eyecare Stock Smart Score

                7
                Neutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10
                The Kits Eyecare stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Kits Eyecare

                Kits Eyecare Ltd is an online retailer of contact lenses and eyewear. Some of the brands of the company include Acuvue, Air Optix Aqua, Biofinity, Cooper Vision, and Bausch & Lomb.

                ---

                Forecast EPS vs Actual EPS


                Similar Stocks
                Company
                Price & Change
                Follow
                Goodfood Market Corp
                Emerge Commerce Ltd
                GOLO Mobile Inc.

                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis